It has been one hot summer, especially here in the Dallas-Fort Worth, Texas, area. We saw a record-breaking streak of consecutive days over 100 °F and without rain.
With the summer months sweltering on, the editors and contributors of Contemporary OB/GYN® have been hard at work carefully crafting a great issue that touches upon a variety of subjects within obstetrics and gynecology.
There are several excellent must-read articles this month:
The cover story is an article by Melissa M. Mauskar, MD; Hunter J. Pyle, BBA; and Audrey K. Rutherford, MD, on vulvovaginal dermatology essentials needed every day to accurately identify various vulvar conditions and determine the appropriate treatment. the authors also provide information on how to best approach patients with vulvovaginal concerns in the clinic.
The Contraception section article, written by Danielle M. Alm, PharmD, BCPs, BCPPs; Reina Puri; and Christine Payne, takes a deep dive into the various contraceptives on the market and describes some best practices for discussing birth control with adolescent patients.
The Practice Matters column by Brian K. Iriye, MD; and James D. Keller, MD, provides thoughtful and informative tips on how to make meetings both effective and efficient.
The Life Transitions section explains the latest phase 3 data for fezolinetant (Astellas Pharma) to treat moderate to severe vasomotor symptoms associated with menopause. The data were presented at the American College of Obstetricians and Gynecologists' Annual Clinical and Scientific Meeting in May 2022 in san Diego, California.
Finally, the Well Woman section features an article by Bertie Geng, MD; and Alla Vash-Margita, MD, about cervical cancer screening guidelines in adolescents. And although average-risk adolescents don’t need Papanicolaou tests, this article gives an update on special populations of adolescent patients who do.
So, as you sit back, relax, and read this August issue of Contemporary OB/GYN® (I hope by a pool or in the shade), please let me know whether there are any topics you would be interested in reading about. Email me at cspong@mjhlifesciences.com.
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More